Total Funding
82
41
Total FundingSeed raised
Growth Score
-5 pts
Heat Score
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
318830
Confluence is a contract research organization providing mechanistic enzymology, target validation, characterization, and more.
Joseph Monahan: President & Co-FounderPast Role: Aclaris Therapeutics, Chief Scientific Officer
Walter Smith: Sr Vice PresidentPast Role: Confluence Life Sciences, CEO
About the Company
Confluence Discovery Technologies is a drug discovery contract research organization (CRO) providing a variety of technical services including mechanistic enzymology, target validation and characterization, screening and assay development, biomarker development and measurement. The company offers its customers novel approaches to identification of
kinase inhibitors along with decades of experience developing clinical candidates for this class. Founders were key scientific leaders in Pfizer's Inflammation Research Unit. Confluence is located at the BioGenerator Accelerator Labs.
